What makes Nicaraguan Caturra different from other coffee cultivars for health purposes?

Nicaraguan Caturra is a compact arabica mutation cultivated in high-altitude Nicaraguan microclimates, which may influence its chlorogenic acid and carotenoid profile relative to other arabica varieties. While comparative phytochemical studies between Caturra and cultivars like Bourbon or Typica are limited, terroir and processing method significantly affect polyphenol concentration. No clinical evidence currently distinguishes its health effects from arabica coffee generally.

Does Nicaraguan Caturra coffee have anti-inflammatory properties?

In vitro studies show that Nicaraguan Caturra extracts reduce nitric oxide (NO), reactive oxygen species (ROS), and SEAP activity in LPS-stimulated macrophages at concentrations up to 400 µg/mL, indicating suppression of NF-κB-linked inflammatory pathways. These findings are limited to cell culture models, and no human or animal trials have confirmed these effects in vivo. Chlorogenic acids and diterpenes such as cafestol are the primary candidate compounds responsible.

Does Nicaraguan Caturra coffee contain vitamin A?

Nicaraguan Caturra may contain carotenoid compounds that function as provitamin A precursors, particularly in the coffee cherry fruit rather than the roasted bean. Beta-carotene and other carotenoids are cleaved by beta-carotene 15,15'-monooxygenase to yield retinol in the body, but the actual carotenoid concentration in this specific cultivar has not been formally quantified. Roasting substantially degrades carotenoids, so vitamin A contribution from brewed coffee is expected to be negligible.

What antioxidants are found in Nicaraguan Caturra coffee?

Nicaraguan Caturra contains chlorogenic acids (primarily 5-caffeoylquinic acid), caffeine, trigonelline, and carotenoids as its principal antioxidant compounds. DPPH and ABTS radical scavenging assays have confirmed free radical neutralizing activity in vitro, though exact IC50 values for this specific cultivar have not been widely published. Chlorogenic acids account for the majority of antioxidant capacity in green arabica coffee, typically ranging from 6–12% dry weight before roasting degrades a significant portion.

Is Nicaraguan Caturra coffee safe to take as a supplement or extract?

Green coffee extracts standardized to chlorogenic acids are generally recognized as safe at doses up to 400 mg/day in most healthy adults, based on broader arabica research, though no Caturra-specific safety studies exist. Caffeine content introduces risk of adverse cardiovascular and neurological effects at high doses, and individuals with hypertension, anxiety disorders, or GERD should exercise caution. No regulatory body has evaluated Nicaraguan Caturra extract specifically, and anyone on anticoagulants, antidiabetics, or MAO inhibitors should consult a physician before use.

How does the growing region affect the antioxidant content in Nicaraguan Caturra coffee?

Nicaraguan Caturra's antioxidant profile is influenced by altitude, soil composition, and climate conditions specific to Nicaragua's coffee-growing regions, which contribute to the DPPH and ABTS radical scavenging activity observed in research. The volcanic soils and tropical climate of Nicaragua create distinct growing conditions compared to other coffee-producing countries, potentially affecting polyphenol and carotenoid concentrations. However, more comparative research between geographic regions is needed to fully establish how Nicaraguan terroir uniquely impacts antioxidant levels.

What is the difference between whole Nicaraguan Caturra coffee and coffee extract supplements?

Whole Nicaraguan Caturra coffee contains the complete plant matrix with naturally occurring compounds, while extracts concentrate specific bioactive components but may lack synergistic compounds found in the whole bean. Extract supplements typically demonstrate higher concentrations of measured antioxidants and anti-inflammatory compounds in controlled laboratory settings, as shown in the in vitro macrophage studies at 400 µg/mL concentrations. The choice between whole coffee and extract depends on intended use, with extracts offering standardized dosing but whole coffee providing a more complex nutritional profile.

Can Nicaraguan Caturra coffee provide meaningful amounts of carotenoids through dietary consumption?

Nicaraguan Caturra coffee pulp contains approximately 808.0 ± 18.3 μg/g of carotenoids, suggesting potential vitamin A contribution when the coffee fruit pulp is incorporated into foods like jams, juices, or supplements. However, the amount of carotenoids absorbed depends on fat content in the meal and individual absorption capacity, as carotenoids are fat-soluble compounds. Most commercial coffee beverages use only the bean, not the fruit pulp, so carotenoid intake from typical coffee consumption may be minimal without specifically selecting whole-fruit coffee products.

Nicaraguan Caturra (Coffea arabica 'Caturra')

Nicaraguan Caturra (Coffea arabica 'Caturra') is an arabica coffee cultivar containing chlorogenic acids, caffeine, and carotenoid precursors that drive its antioxidant and anti-inflammatory properties. Its polyphenolic compounds scavenge free radicals and suppress pro-inflammatory signaling via NF-κB-linked pathways in macrophage models.

Category: Coffee Cultivars Evidence: 2/10 Tier: Emerging

Nicaraguan Caturra (Coffea arabica 'Caturra') — Hermetica Encyclopedia

Origin & History

Nicaraguan Caturra (Coffea arabica 'Caturra') is a compact, high-yield coffee cultivar variant originating from a natural mutation of the Bourbon variety discovered in Brazil in the 1930s-1940s and widely cultivated in Central America. The cultivar's bioactive compounds are primarily extracted from its pulp using ultrasound-assisted extraction with ethanol:ethyl acetate solvents, yielding carotenoid-rich extracts.

Historical & Cultural Context

No evidence of traditional medicinal use for Nicaraguan Caturra was identified in available sources. This cultivar has been primarily valued as an agronomic variety selected for coffee production yield since its propagation in Central America, with bioactive compound research on its by-products emerging only recently.

Health Benefits

• Antioxidant activity demonstrated through in vitro DPPH and ABTS radical scavenging assays (preliminary evidence)
• Anti-inflammatory effects shown via reduction of NO, ROS, and SEAP in LPS-stimulated macrophages at concentrations up to 400 µg/mL (in vitro evidence only)
• Potential vitamin A contribution from carotenoid content (808.0 ± 18.3 μg/g in yellow pulp) when incorporated in foods (food application study, not clinical)
• Rich source of dietary fiber from pulp by-products (composition data only, no clinical validation)
• No cytotoxicity observed in cell studies up to 400 µg/mL (preliminary safety data)

How It Works

Chlorogenic acids in Nicaraguan Caturra inhibit free radical chain reactions by donating hydrogen atoms to DPPH and ABTS radicals, as confirmed in vitro. In LPS-stimulated macrophages, its bioactive compounds suppress nitric oxide (NO) and reactive oxygen species (ROS) production, likely by downregulating iNOS expression and NF-κB activation, reducing SEAP reporter activity at concentrations up to 400 µg/mL. Additionally, carotenoid compounds present in the green coffee cherry may serve as provitamin A precursors, potentially supporting retinol biosynthesis via beta-carotene cleavage enzymes.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Nicaraguan Caturra as a biomedical ingredient. Current evidence is limited to in vitro antioxidant capacity assessments and anti-inflammatory effects in LPS-treated RAW-Blue cells, with no PubMed-indexed human studies available for this specific cultivar.

Clinical Summary

Current evidence for Nicaraguan Caturra is limited entirely to in vitro studies; no human clinical trials or animal intervention studies have been published specifically on this cultivar. DPPH and ABTS radical scavenging assays demonstrate meaningful antioxidant capacity, though these cell-free models do not confirm bioavailability or in vivo efficacy. Anti-inflammatory outcomes — including reductions in NO, ROS, and SEAP — were observed in LPS-challenged macrophage cell lines at doses up to 400 µg/mL, a concentration difficult to extrapolate to physiological human exposure. The potential vitamin A content requires quantification through validated chromatographic methods before any nutritional claims can be substantiated.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 10-12% by weight", "fiber": "Dietary fiber content is around 3-5% by weight"}, "micronutrients": {"vitamins": {"vitamin_A": "Carotenoid content contributing approximately 808.0 \u00b1 18.3 \u03bcg/g in yellow pulp"}, "minerals": {"potassium": "Approximately 1,200 mg per 100g", "magnesium": "Around 100 mg per 100g"}}, "bioactive_compounds": {"antioxidants": {"chlorogenic_acid": "Estimated at 2-5% of dry weight", "caffeine": "Approximately 1.2-1.5% by weight"}}, "bioavailability_notes": "The bioavailability of carotenoids can be enhanced when consumed with dietary fats. Chlorogenic acids are known to be partially absorbed in the small intestine, with some metabolism occurring in the colon."}

Preparation & Dosage

No clinically studied dosage ranges exist for Nicaraguan Caturra in humans. In food applications, encapsulated carotenoid extract from yellow Caturra pulp was added at 9.5% (w/v) to yogurt, but this lacks clinical standardization for supplement use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin A, lutein, zeaxanthin, beta-carotene, quercetin

Safety & Interactions

As a Coffea arabica cultivar, Nicaraguan Caturra contains caffeine, which may cause insomnia, tachycardia, and elevated blood pressure at high intake levels, particularly in caffeine-sensitive individuals. Chlorogenic acids can modestly reduce postprandial glucose absorption and may potentiate hypoglycemic medications, warranting caution in diabetic patients on metformin or insulin. Pregnant individuals should limit caffeine consumption to under 200 mg per day per WHO guidance, as higher intake is associated with increased risk of fetal growth restriction. No cultivar-specific drug interaction data exists; interactions attributed to coffee broadly — including interference with adenosine receptor antagonism and MAO inhibitor combinations — are presumed applicable.